Interview: Iwer Baecker – Managing Director, Bayer Ireland
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Address: The Atrium, Blackthorn road, Dublin 18,Ireland
Tel: +353 1 2999313
Web: http://www.bayer.ie/scripts/pages/en/index.php
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2011, the Group employed about 112,000 people and had sales of €36.5 billion. Capital expenditures amounted to €1.7 billion, R&D expenses to €2.9 billion.
Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. This subgroup’s mission is to research, develop, manufacture and market innovative products that improve the health of people and animals throughout the world.
The globally operating Health Care subgroup is divided into four operating divisions: The goals of the Animal Health Division are to maintain the health of animals and cure veterinary diseases, with the focus primarily on treating infectious diseases and repelling parasites. The main focus of the Consumer Care Division is on non-prescription medicines and dietary supplements. One example is Aspirin, a more than 110-year-old brand that enjoys an unsurpassed level of global familiarity. Medical Care comprises the businesses with blood glucose monitoring devices and medical equipment for diagnosis and treatment.
The Pharmaceuticals Division is today the highest-selling pharmaceuticals company in Germany and holds a worldwide leading position in its main therapeutic areas. The focus is on prescription medicines. The division combines its strengths in two business units: General Medicine and Specialty Medicine.
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Darren Cunningham tells us the story behind Inflection Biosciences (and its name), the rationale of focusing on small molecule cancer treatments, his thoughts on the Irish biotech start-up scene, and his hopes…
Richard Corbridge, first Chief Information Officer of the Health Service Executive (HSE) and CEO of the newly created eHealth Ireland, discusses Ireland’s ambitious plan to construct a new digital health…
Dr. Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), the Irish regulatory agency, discusses the key objectives of the Strategic Plan 2016–2020, HPRA’s active participation in European…
Dermot O’Callaghan, cofounder and Director of Business Development, tells us the exciting story behind the genesis of Enterprise System Partners, an Irish success story providing manufacturing execution systems (MES) and…
Jack Daly, Commercial Manager at IMS Health Ireland, discusses the strategic decision of IMS Health to diversify into the health consultancy space, the importance of developing long-term partnerships with clients…
Colin Edwards, CEO of Merlin Consulting, a consulting firm providing services to the pharma, life sciences and digital health sectors in Ireland, discusses his reasons for leaving Boehringer Ingelheim to…
Dave Murphy, CEO of PM Group, the largest local service provider to the pharma industry in Ireland, highlights key developments of the group since 2013, their exciting internationalization and acquisition…
In an exclusive interview, Irish Minister for Foreign Affairs and Trade, Charles Flanagan TD, outlines the Department’s enhanced focus on trade and economic recovery, Ireland’s commitment to productive global engagement,…
Una Halligan, Chairperson of the Expert Group on Future Skills Needs (EGFSN), outlines the findings of its recently published report on the biopharma industry, the advantages Ireland can offer the…
Niall Barron, director of the NICB, discusses the Institute’s research, which has included significant research into Chinese Hamster Ovary (CHO) cell engineering and the identification of micro-RNA mechanisms that can…
Geraldine Freeman, Commercial Director at Johnson & Johnson Consumer Business in Ireland, discusses the increasing trend towards self-care in Ireland and the importance of the self-care agenda within the context…
Tony O’Brien, Director General of the Irish Health Service Executive (HSE), highlights the reforms instituted in the past few years, key challenges faced, his thoughts on the sustainability of the…
See our Cookie Privacy Policy Here